Wanbury Ltd Hits All-Time High of Rs 347.1 as Momentum Builds Across Timeframes

1 hour ago
share
Share Via
Wanbury Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high price of Rs.347.1 on 14 July 2026, marking a significant milestone in its market journey. This achievement reflects the company’s robust performance and sustained upward momentum over recent months.
Wanbury Ltd Hits All-Time High of Rs 347.1 as Momentum Builds Across Timeframes

Price Action and Recent Performance

The stock's intraday high of Rs 347.1 marked a 15.41% jump from its previous close, with a day gain of 13.08%. This surge was supported by a significant increase in delivery volumes, which rose by 261.4% compared to the five-day average, signalling robust investor participation. Wanbury is currently trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — reflecting a sustained upward momentum across multiple timeframes. Over the past month, the stock has gained 23.90%, while the Sensex managed a modest 2.19% rise, highlighting Wanbury's outperformance in a mixed market environment. What factors are driving such a strong multi-month rally in Wanbury compared to the broader market?

Technical Indicators Signal Mildly Bullish Momentum

Technically, Wanbury Ltd exhibits a mildly bullish trend, confirmed on 13 Jul 2026 when the price crossed ₹300.75. Key indicators such as the MACD and Bollinger Bands on the weekly chart are bullish, while monthly signals show some mild bearishness in MACD and KST, suggesting a nuanced momentum picture. The stock's RSI and OBV currently show no clear trend, indicating that volume and relative strength are not yet overextended. Immediate support lies at the 52-week low of ₹162.00, while resistance levels to watch include the 20-day moving average near ₹279.02 and the 52-week high at ₹350.55. The strong delivery volume increase over the past month (137.62%) further supports the technical momentum. Does the current technical setup suggest the rally has room to run, or is a pullback imminent?

Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!

  • - Reliable Performer certified
  • - Consistent execution proven
  • - Large Cap safety pick

Get Safe Returns →

Valuation Multiples Reflect Premium Pricing

At a trailing twelve months (TTM) price-to-earnings (P/E) ratio of 24x, Wanbury Ltd trades at a premium relative to many peers in the Pharmaceuticals & Biotechnology sector. The price-to-book value (P/BV) ratio stands at a lofty 17.73x, while EV/EBITDA and EV/EBIT ratios are 13.81x and 16.34x respectively, indicating stretched valuations. However, the PEG ratio of 0.21x suggests that earnings growth is currently outpacing the price multiple, which may partly justify the premium. The stock’s enterprise value to sales ratio of 1.93x and EV to capital employed of 5.44x further highlight the market’s willingness to pay for growth. At a P/E of 24x and elevated price-to-book, is Wanbury Ltd still worth holding — or is it time to reassess?

Financial Trend Shows Strong Quarterly Growth

The latest quarterly results for Wanbury Ltd reveal a positive financial trend. Operating profit to interest coverage reached a high of 3.70 times, while PBDIT hit ₹29.85 crores, the highest recorded. Operating profit margin improved to 18.14%, and profit before tax excluding other income rose to ₹18.56 crores. Net profit after tax surged to ₹25.30 crores, with earnings per share (EPS) at ₹6.21, also a record high. These figures indicate robust operational performance and effective cost management. Could this strong quarterly momentum sustain the stock’s rally, or are these gains already priced in?

Quality Metrics Highlight Strong Returns but Elevated Leverage

Assessing the quality of Wanbury Ltd, the company demonstrates very strong returns with an average return on capital employed (ROCE) of 30.89% and return on equity (ROE) of 42.23%. Sales growth over five years averaged 10.62%, while EBIT growth was a robust 62.06%. However, the capital structure shows some concerns, with an average net debt to equity ratio of 2.77 indicating high leverage, and an average EBIT to interest coverage ratio of 1.29x, which is relatively weak. Institutional holdings are low at 0.59%, and pledged shares are high at 86.69%, factors that may warrant investor attention. How do these mixed quality signals affect the sustainability of Wanbury’s recent price gains?

Wanbury Ltd or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Key Data at a Glance

Current Price
Rs 340.10
52-Week Range
Rs 162.00 - Rs 350.55
P/E Ratio (TTM)
24x
Price to Book Value
17.73x
EV/EBITDA
13.81x
ROCE (5-Year Avg.)
30.89%
ROE (5-Year Avg.)
42.23%
5-Year Sales Growth CAGR
10.62%

Balancing the Bull and Bear Cases

The recent surge in Wanbury Ltd shares reflects a combination of strong quarterly earnings growth, positive technical momentum, and sustained outperformance relative to the Sensex and sector peers. The stock’s trading above all major moving averages and the sharp increase in delivery volumes lend technical support to the rally. However, the elevated valuation multiples, particularly the high price-to-book ratio and premium P/E, suggest that the market has priced in significant growth expectations. Additionally, the company’s high leverage and substantial pledged shares introduce elements of risk that investors should consider. Should you buy, sell, or hold? With momentum and valuations pulling in opposite directions, no single data point tells the full story — see the complete multi-factor analysis of Wanbury Ltd to find out.

Conclusion

Wanbury Ltd has reached a significant milestone by touching an all-time high of Rs 347.1, fuelled by a blend of strong earnings, technical strength, and sustained outperformance. While the momentum appears supportive in the near term, the stretched valuations and capital structure considerations suggest that caution may be warranted. Investors may wish to closely monitor upcoming quarterly results and technical signals to gauge whether the stock can maintain its upward trajectory or if profit booking could emerge at these levels.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News